** Shares of telehealth firm Hims & Hers HIMS.N fall 6.2% to $37.98 premarket

** Novo Nordisk NOVOb.CO says it would offer doses of its weight-loss drug Wegovy at a reduced cost of $499 per month for cash paying customers in the United States

** Wegovy has a list price of around $1,350 a month, regardless of dosage

** Discounted drugs will be distributed through a program called NovoCare Pharmacy to uninsured patients or those whose insurance does not cover obesity medicines

** HIMS has benefited from selling cheaper copies, or compounded versions, of Wegovy

** Telehealth firm's shares have nearly tripled in the past 12 months

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com;))